Pfizer announced today that “its coronavirus vaccine trial was effective in preventing COVID-19 infections in 90% of previously uninfected people and did not produce any serious safety concerns”.

Note that this is only Phase 3 data, and that long-term safety and efficacy data is mandated. But this announcement does signify a breakthrough on the road to a COVID-19 vaccine.